Hypertension is a leading risk factor for disease burden globally. An unresolved question is whether grade 1 hypertension (140-159/90-99mmHg) with low (cardiovascular mortality <1% at 10 years) to moderate (cardiovascular mortality ≥1% and <5% at 10 years) absolute total cardiovascular risk (CVR) should be treated with antihypertensive agents. A virtual international consultation process was undertaken to summarize the opinions of select experts.
View Article and Find Full Text PDFHypertensive crises lumped several clinical situations with different seriousness and prognosis. The differences between hypertensive urgency and hypertensive emergency depends on if this situation involves a vital risk for the patient. This risk is defined more by the severity of the organ damage than for the higher values of blood pressure.
View Article and Find Full Text PDFCardiovascular diseases prevention strategies require refinement because their incidence decreases very slowly. Risk functions were developed by including classical cardiovascular risk factors (age, sex, smoking, diabetes, blood pressure, and basic lipid profile) in cohorts followed more than 10 years. They are reasonably precise for population screening of, principally, coronary artery disease risk, required in all cardiovascular primary prevention clinical guidelines.
View Article and Find Full Text PDFBetween the end of 2013 and the beginning of 2014 the most internationally influential hypertension guidelines were published. Although there are no major differences between them, there are discrepancies that can have an impact on treatment and prognosis for individuals with hypertension. This article analyzes the main controversial elements in the guides and presents the recommendations of the Sociedad Centroamericana y del Caribe de Hipertensión y Prevención Cardiovascular (Caribbean Society for Hypertension and Cardiovascular Prevention).
View Article and Find Full Text PDFRev Esp Cardiol (Engl Ed)
December 2014
Background And Objective: Evidence shows that pulse pressure (PP) is very useful when assessing the hypertensive patient and this has led to a lower use of mean arterial pressure (MAP). We intended to demonstrate that MAP should be better than PP in young hypertensive patients.
Subjects And Method: Cross-sectional study in 70 white males with ages among 16-40 years, distributed in two groups of 35 individuals labelled as control group or hypertensive patients, who were assessed by echocardiography.